Please login to the form below

Not currently logged in

Lilly launches diabetes partnership programme in South Africa

Partners with Project Hope and Donald Woods Foundation

Lilly has extended its non-communicable diseases (NCD) partnership programme to South Africa, where it has joined with Project Hope and Donald Woods Foundation (DWF) to help tackle the rise in diabetes.

The Lilly NCD Partnership programme was set up in 2011, with an investment of US$30m over five years. The aim of the partnerships has been to develop new approaches to managing NCDs, such as diabetes, cancer and heart disease, in the developing world.

South Africa is expected to experience the highest growth rate of diabetes in the world over the next 20 years, according to Lilly's corporate communications director, corporate social responsibility, David Marbaugh.

“Ultimately, the goal of the Lilly NCD Partnership is to find new, cost-effective solutions that can be replicated and scaled up by governments around the world,” he said, writing on Lilly's corporate blog. “Our initial focus is on diabetes in disadvantaged communities in Brazil, India, Mexico, and South Africa.”

Part of this process will involve community outreach and support through preventative screening, diagnosis and treatment services, and health education programmes.

According to the World Health Organization (WHO), non-communicable diseases account for 63 per cent of global deaths and nearly 80 per cent of deaths in low- to middle-income countries.

WHO members last week agreed the first-ever global monitoring framework to combat NCDs like heart disease, diabetes, cancer and chronic lung disease with nine voluntary global targets and 25 indicators to help prevent and control them.

12th November 2012

From: Research, Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
Emotional Intelligence and Blended Learning in Healthcare
EI and emotional selling are rising up the agenda when it comes to healthcare training. This article outlines how blended learning approaches can help put them into action....